High temperature and high beam current compatible targets and methods thereof for generating noble gas/radiohalogen generators for medical isotopes
A method of providing alpha particle emitters and materials suitable for use in generating the alpha particles for medical treatment is disclosed. Metal oxide targets, preferentially Bi2O3 pellets and Bi2O3 coatings on metallic or metal oxide substrates are formed. The targets placed in a heated vacuum chamber subjecting to irradiation using a 6Li beam at an elevated temperature below the melting point of the target generate a radioactive gas, such as 211Rn, the radioactive gas is carried by an inert gas which is delivered a carrier for, such as a carbon column or oil for delivery to a treatment facility. The radioactive gas such as 211Rn generates 211At, which has a useable half-life of at least about 14 hours, in turn releases alpha particles which are effective for use in medical procedures.
- Research Organization:
- Innosense LLC, Torrance, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- SC0007572; SC0019587
- Assignee:
- Innosense LLC (Torrance, CA)
- Patent Number(s):
- 11,776,705
- Application Number:
- 17/151,147
- OSTI ID:
- 2293674
- Resource Relation:
- Patent File Date: 01/16/2021
- Country of Publication:
- United States
- Language:
- English
Similar Records
Enhancing Radionuclide Production Capabilities at the Duke University Medical Center Cyclotron with a Focus on Astatine-211
Production of Astatine-211 at the Duke University Medical Center for its regional distribution